[
  {
    "title": "东诚药业(002675.SZ)：“核药房建设项目”延期",
    "href": "http://stock.jrj.com.cn/2022/12/29222037247891.shtml",
    "datetime": "2022-12-29 22:20:00",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：氟[18F]纤抑素注射液获批临床",
    "href": "http://stock.jrj.com.cn/2022/12/21185437229223.shtml",
    "datetime": "2022-12-21 18:54:36",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：肝素钠原料药通过韩国官方定期审计",
    "href": "http://stock.jrj.com.cn/2022/12/19172837222871.shtml",
    "datetime": "2022-12-19 17:28:18",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：东诚核医疗近日收到政府补助1000万元",
    "href": "http://stock.jrj.com.cn/2022/12/14180937212557.shtml",
    "datetime": "2022-12-14 18:09:15",
    "code": "002675"
  },
  {
    "title": "东诚药业拟2.1亿收购加码核药转型 标的前三季赚1352万承诺两年揽收2.5亿",
    "href": "http://stock.jrj.com.cn/2022/12/13110437208250.shtml",
    "datetime": "2022-12-13 11:04:49",
    "code": "002675"
  },
  {
    "title": "东诚药业：下属公司拟收购XING IMAGING LLC100%股权",
    "href": "http://stock.jrj.com.cn/2022/12/11203137204074.shtml",
    "datetime": "2022-12-11 20:31:59",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：下属公司3020万美元收购XING IMAGING LLC100%股权",
    "href": "http://stock.jrj.com.cn/2022/12/11172437203944.shtml",
    "datetime": "2022-12-11 17:24:17",
    "code": "002675"
  },
  {
    "title": "东诚药业：子公司通过药品GMP现场符合性检查",
    "href": "http://stock.jrj.com.cn/2022/12/07171137195338.shtml",
    "datetime": "2022-12-07 17:11:01",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：子公司引进Tau蛋白正电子摄影示踪剂产品",
    "href": "http://stock.jrj.com.cn/2022/12/07165737195287.shtml",
    "datetime": "2022-12-07 16:57:27",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：子公司东诚北方通过药品GMP现场符合性检查",
    "href": "http://stock.jrj.com.cn/2022/12/07165237195292.shtml",
    "datetime": "2022-12-07 16:52:38",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：子公司安迪科被认定为江苏省专精特新中小企业",
    "href": "http://stock.jrj.com.cn/2022/11/25164937167081.shtml",
    "datetime": "2022-11-25 16:49:49",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：东诚北方那屈肝素钙注射液获批上市",
    "href": "http://stock.jrj.com.cn/2022/11/08155437120370.shtml",
    "datetime": "2022-11-08 15:54:21",
    "code": "002675"
  },
  {
    "title": "东诚药业：子公司那屈肝素钙注射液获批生产上市",
    "href": "http://stock.jrj.com.cn/2022/11/08155137120339.shtml",
    "datetime": "2022-11-08 15:51:12",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：碘[125I]密封籽源新增规格(长度4.5mm×外径0.60mm)获批上市",
    "href": "http://stock.jrj.com.cn/2022/11/07174637117697.shtml",
    "datetime": "2022-11-07 17:46:55",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：辽宁沈阳核药房投入运营",
    "href": "http://stock.jrj.com.cn/2022/11/06175637115349.shtml",
    "datetime": "2022-11-06 17:56:22",
    "code": "002675"
  },
  {
    "title": "东诚药业2022年前三季度净利3.3亿同比增长26.17% 产生汇兑收益、财务费用下降",
    "href": "http://stock.jrj.com.cn/2022/10/27201137091077.shtml",
    "datetime": "2022-10-27 20:11:54",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)第三季度净利1.62亿元 同比增长51.22%",
    "href": "http://stock.jrj.com.cn/2022/10/27191737090767.shtml",
    "datetime": "2022-10-27 19:17:42",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：重庆核药房与昆明核药房投入运营",
    "href": "http://stock.jrj.com.cn/2022/10/09161837041620.shtml",
    "datetime": "2022-10-09 16:18:24",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：控股股东解质135万股",
    "href": "http://stock.jrj.com.cn/2022/09/20175637008628.shtml",
    "datetime": "2022-09-20 17:56:59",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：控股股东质押1293.2万股",
    "href": "http://stock.jrj.com.cn/2022/09/19210537006198.shtml",
    "datetime": "2022-09-19 21:05:25",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：控股股东及实控人质押合计4829.32万股",
    "href": "http://stock.jrj.com.cn/2022/09/06185736977813.shtml",
    "datetime": "2022-09-06 18:57:46",
    "code": "002675"
  },
  {
    "title": "东诚药业实际控制人由守谊质押113.5万股 用于补充质押",
    "href": "http://stock.jrj.com.cn/2022/09/01205036964291.shtml",
    "datetime": "2022-09-01 20:50:19",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)半年度净利润1.69亿元 同比增长8.89%",
    "href": "http://stock.jrj.com.cn/2022/08/25212536937449.shtml",
    "datetime": "2022-08-25 21:25:01",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：氟[18F]思睿肽注射液获批临床",
    "href": "http://stock.jrj.com.cn/2022/07/29170536854193.shtml",
    "datetime": "2022-07-29 17:05:22",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：下属公司7月18日获得政府补助9000万元",
    "href": "http://stock.jrj.com.cn/2022/07/18172536821702.shtml",
    "datetime": "2022-07-18 17:25:01",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：安迪科与ImaginAb签署相关许可协议",
    "href": "http://stock.jrj.com.cn/2022/05/23154636670318.shtml",
    "datetime": "2022-05-23 15:46:59",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：获批非公开发行不超3091.87万股新股",
    "href": "http://stock.jrj.com.cn/2022/05/17174736655732.shtml",
    "datetime": "2022-05-17 17:47:37",
    "code": "002675"
  },
  {
    "title": "东诚药业2022年第一季度净利5492.19万同比下滑17.9% 云克注射液收入下滑",
    "href": "http://stock.jrj.com.cn/2022/05/03185036546057.shtml",
    "datetime": "2022-05-03 18:50:38",
    "code": "002675"
  },
  {
    "title": "东诚药业2021年净利1.52亿同比下滑63.72% 董事长由守谊薪酬80.35万",
    "href": "http://stock.jrj.com.cn/2022/04/29095036501352.shtml",
    "datetime": "2022-04-29 09:50:38",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：子公司拟1.5亿元收购南京云米70.28%合伙份额和南京米安北99.90%合伙份额",
    "href": "http://stock.jrj.com.cn/2022/04/13165136324460.shtml",
    "datetime": "2022-04-13 16:51:22",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：下属公司烟台安迪科收到政府补助资金1亿元",
    "href": "http://stock.jrj.com.cn/2022/04/07181136268778.shtml",
    "datetime": "2022-04-07 18:11:54",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：安迪科的武汉核药房投入运营",
    "href": "http://stock.jrj.com.cn/2022/03/15163634829313.shtml",
    "datetime": "2022-03-15 16:36:51",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)2021年度净利润预降59.31%-67.69%",
    "href": "http://stock.jrj.com.cn/2022/02/04145234288556.shtml",
    "datetime": "2022-02-04 14:52:45",
    "code": "002675"
  },
  {
    "title": "东诚药业2021年预计净利1.35亿-1.7亿同比下降59%-68% 毛利率下降",
    "href": "http://stock.jrj.com.cn/2022/01/29151034257180.shtml",
    "datetime": "2022-01-29 15:10:51",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：安迪科的福州核药房投入运营",
    "href": "http://stock.jrj.com.cn/2022/01/25210334214056.shtml",
    "datetime": "2022-01-25 21:03:53",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：子公司安迪科与ImaginAb签署合作意向书 进入免疫治疗领域",
    "href": "http://stock.jrj.com.cn/2022/01/10201334142692.shtml",
    "datetime": "2022-01-10 20:13:47",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：非公开发行A股股票申请获证监会受理",
    "href": "http://stock.jrj.com.cn/2022/01/07202934134849.shtml",
    "datetime": "2022-01-07 20:29:31",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：子公司青岛核药房通过药品GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2021/12/20204034036480.shtml",
    "datetime": "2021-12-20 20:40:38",
    "code": "002675"
  },
  {
    "title": "东诚药业总经理忻红波辞职 罗志刚接任 第三季度公司净利1.07亿",
    "href": "http://stock.jrj.com.cn/2021/12/14213234016266.shtml",
    "datetime": "2021-12-14 21:32:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：聘任罗志刚担任总经理职务",
    "href": "http://stock.jrj.com.cn/2021/12/14211134026033.shtml",
    "datetime": "2021-12-14 21:11:00",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：总经理忻红波辞职 由罗志刚接任",
    "href": "http://stock.jrj.com.cn/2021/12/14184434015286.shtml",
    "datetime": "2021-12-14 18:44:06",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)1581.9万股限售股份12月14日上市流通",
    "href": "http://stock.jrj.com.cn/2021/12/12172833999661.shtml",
    "datetime": "2021-12-12 17:28:37",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：湖南核药房通过药品GMP符合性检查",
    "href": "http://stock.jrj.com.cn/2021/11/23181433910343.shtml",
    "datetime": "2021-11-23 18:14:39",
    "code": "002675"
  },
  {
    "title": "A股异动 | 东诚药业(002675.SZ)接近涨停 拟定增募资不超3.5亿元",
    "href": "http://stock.jrj.com.cn/2021/11/04094633811495.shtml",
    "datetime": "2021-11-04 09:46:27",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：嘉兴聚力减持期届满 累计减持100股",
    "href": "http://stock.jrj.com.cn/2021/11/03193833809447.shtml",
    "datetime": "2021-11-03 19:38:05",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：拟向实控人由守谊定增募资不超3.5亿元 用于补流和偿还有息负债",
    "href": "http://stock.jrj.com.cn/2021/11/03185033809325.shtml",
    "datetime": "2021-11-03 18:50:55",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：控股股东质押892.5万股及解押681.6878万股",
    "href": "http://stock.jrj.com.cn/2021/11/01222933800148.shtml",
    "datetime": "2021-11-01 22:29:22",
    "code": "002675"
  },
  {
    "title": "东诚药业：前三季度实现净利润2.62亿元，同比下降22.59%",
    "href": "http://stock.jrj.com.cn/2021/10/30104533782548.shtml",
    "datetime": "2021-10-30 10:45:19",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：第三季度净利降10.19%至1.07亿元",
    "href": "http://stock.jrj.com.cn/2021/10/28182433770834.shtml",
    "datetime": "2021-10-28 18:24:26",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：控股股东质押945万股",
    "href": "http://stock.jrj.com.cn/2021/10/07192333646863.shtml",
    "datetime": "2021-10-07 19:23:36",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：减持期过半 嘉兴聚力已减持100股",
    "href": "http://stock.jrj.com.cn/2021/09/17200033453071.shtml",
    "datetime": "2021-09-17 20:00:11",
    "code": "002675"
  },
  {
    "title": "东诚药业子公司被生态环境部责令整改 辐射环境违法",
    "href": "http://stock.jrj.com.cn/2021/09/06172533392758.shtml",
    "datetime": "2021-09-06 17:25:00",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：拟转让蓝纳成股权予公司股权及期权激励平台",
    "href": "http://stock.jrj.com.cn/2021/09/02203433375783.shtml",
    "datetime": "2021-09-02 20:34:44",
    "code": "002675"
  },
  {
    "title": "东诚药业成本上升原料药毛利降38% 核药业绩显颓势近26亿商誉减值压顶",
    "href": "http://stock.jrj.com.cn/2021/08/09072533223065.shtml",
    "datetime": "2021-08-09 07:25:03",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：嘉兴聚力持股比例降至5%以下",
    "href": "http://stock.jrj.com.cn/2021/08/05174033207988.shtml",
    "datetime": "2021-08-05 17:40:15",
    "code": "002675"
  },
  {
    "title": "东诚药业2021年上半年净利1.55亿下滑29.32% 肝素钠主营业务成本上升",
    "href": "http://stock.jrj.com.cn/2021/07/27212633159864.shtml",
    "datetime": "2021-07-27 21:26:28",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)上半年净利降29.32%至1.55亿元",
    "href": "http://stock.jrj.com.cn/2021/07/27183833159150.shtml",
    "datetime": "2021-07-27 18:38:20",
    "code": "002675"
  },
  {
    "title": "A股异动 | 东诚药业(002675.SZ)跌逾5% 股东嘉兴聚力拟减持不超1%股份",
    "href": "http://stock.jrj.com.cn/2021/07/14141433094460.shtml",
    "datetime": "2021-07-14 14:14:40",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：股东嘉兴聚力拟减持不超1.00%股份",
    "href": "http://stock.jrj.com.cn/2021/07/13204433090910.shtml",
    "datetime": "2021-07-13 20:44:57",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：5607.6568万股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/06/14185332926609.shtml",
    "datetime": "2021-06-14 18:53:06",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：认购APRINOIA Therapeutics Inc.股权交割完成",
    "href": "http://stock.jrj.com.cn/2021/06/08213332895788.shtml",
    "datetime": "2021-06-08 21:33:29",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：盐酸氨溴索分散片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/28200832836729.shtml",
    "datetime": "2021-05-28 20:08:10",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)2020年度权益分派10派2.5元 股权登记日为6月3日",
    "href": "http://stock.jrj.com.cn/2021/05/27174032830719.shtml",
    "datetime": "2021-05-27 17:40:30",
    "code": "002675"
  },
  {
    "title": "东诚药业：采用生物药与化药联合用药治疗已成为趋势",
    "href": "http://stock.jrj.com.cn/2021/05/13065032745327.shtml",
    "datetime": "2021-05-13 06:50:34",
    "code": "002675"
  },
  {
    "title": "东诚药业：2017年后 先后收购了安迪科 广东高尚4个核药房",
    "href": "http://stock.jrj.com.cn/2021/05/12110432740886.shtml",
    "datetime": "2021-05-12 11:04:55",
    "code": "002675"
  },
  {
    "title": "【龙虎榜】东诚药业4月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/04/30180132488202.shtml",
    "datetime": "2021-04-30 18:01:23",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：一季度净利6689.81万元 同比下降9.44%",
    "href": "http://stock.jrj.com.cn/2021/04/30080132484345.shtml",
    "datetime": "2021-04-30 08:01:20",
    "code": "002675"
  },
  {
    "title": "东诚药业：核医药板块为公司重点发展板块",
    "href": "http://stock.jrj.com.cn/2021/02/25074332022825.shtml",
    "datetime": "2021-02-25 07:43:05",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)拟投资 APRINOIA Therapeutics Inc. 持股预计16%",
    "href": "http://stock.jrj.com.cn/2021/02/05193031855973.shtml",
    "datetime": "2021-02-05 19:30:28",
    "code": "002675"
  },
  {
    "title": "东诚药业2020年预计净利4亿-4.5亿增长158.54%-190.86% 原料药业务增长",
    "href": "http://stock.jrj.com.cn/2021/01/26205931780357.shtml",
    "datetime": "2021-01-26 20:59:14",
    "code": "002675"
  },
  {
    "title": "[东诚药业]“融合 创新”—东诚药业2021线上直播年会隆重举行",
    "href": "http://stock.jrj.com.cn/2021/01/25000031771320.shtml",
    "datetime": "2021-01-25 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)通过高新技术企业重新认定及下属公司通过高新技术企业认定",
    "href": "http://stock.jrj.com.cn/2021/01/18155631715365.shtml",
    "datetime": "2021-01-18 15:56:32",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：控股股东解除质押2065万股",
    "href": "http://stock.jrj.com.cn/2021/01/08193931657192.shtml",
    "datetime": "2021-01-08 19:39:29",
    "code": "002675"
  },
  {
    "title": "【龙虎榜】东诚药业12月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/12/18180131519628.shtml",
    "datetime": "2020-12-18 18:01:13",
    "code": "002675"
  },
  {
    "title": "[东诚药业]集团成功召开2020年第三季度经营管理会",
    "href": "http://stock.jrj.com.cn/2020/10/30000031196360.shtml",
    "datetime": "2020-10-30 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/27000031136990.shtml",
    "datetime": "2020-10-27 00:00:02",
    "code": "002675"
  },
  {
    "title": "东诚药业2020年前三季度净利3.38亿增长21.27% 销量增加",
    "href": "http://stock.jrj.com.cn/2020/10/26203431136052.shtml",
    "datetime": "2020-10-26 20:34:52",
    "code": "002675"
  },
  {
    "title": "东诚药业：全资子公司安迪科与通用电气药业签署许可协议 引入国外成熟原研产品",
    "href": "http://stock.jrj.com.cn/2020/10/21194031102180.shtml",
    "datetime": "2020-10-21 19:40:52",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：与通用电气药业签署许可协议",
    "href": "http://stock.jrj.com.cn/2020/10/21181331101782.shtml",
    "datetime": "2020-10-21 18:13:42",
    "code": "002675"
  },
  {
    "title": "东诚药业跌停 西部证券财通证券高位喊买入帮割韭菜",
    "href": "http://stock.jrj.com.cn/2020/09/28185130854535.shtml",
    "datetime": "2020-09-28 18:51:00",
    "code": "002675"
  },
  {
    "title": "【龙虎榜】东诚药业9月28日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/09/28180130854339.shtml",
    "datetime": "2020-09-28 18:01:34",
    "code": "002675"
  },
  {
    "title": "近一周机构调研130余股 扎堆卫宁健康、东诚药业等",
    "href": "http://stock.jrj.com.cn/hotstock/2020/09/21075530798157.shtml",
    "datetime": "2020-09-21 07:55:03",
    "code": "002675"
  },
  {
    "title": "东诚药业股东鲁鼎思诚减持1001.42万股 套现约2.34亿元",
    "href": "http://stock.jrj.com.cn/2020/09/18203830778896.shtml",
    "datetime": "2020-09-18 20:38:28",
    "code": "002675"
  },
  {
    "title": "东诚药业(002675.SZ)：股东鲁鼎思诚已减持1%公司股份",
    "href": "http://stock.jrj.com.cn/2020/09/11181030731670.shtml",
    "datetime": "2020-09-11 18:10:33",
    "code": "002675"
  },
  {
    "title": "东诚药业25亿元商誉创新高 核药呈颓势高管精准减持",
    "href": "http://stock.jrj.com.cn/2020/08/19073130534970.shtml",
    "datetime": "2020-08-19 07:31:47",
    "code": "002675"
  },
  {
    "title": "东诚药业2020年上半年净利2.19亿增长23.05% 销售增加",
    "href": "http://stock.jrj.com.cn/2020/08/06191530443589.shtml",
    "datetime": "2020-08-06 19:15:37",
    "code": "002675"
  },
  {
    "title": "东诚药业半年报：上半年净利润2.19亿元 同比增长23.05%",
    "href": "http://stock.jrj.com.cn/2020/08/06155030441868.shtml",
    "datetime": "2020-08-06 15:50:51",
    "code": "002675"
  },
  {
    "title": "[互动]东诚药业：肝素原料药销售较往年增长明显",
    "href": "http://stock.jrj.com.cn/2020/07/27103330352987.shtml",
    "datetime": "2020-07-27 10:33:53",
    "code": "002675"
  },
  {
    "title": "[东诚药业]集团成功召开2020年第二季度经营管理暨半年总结会",
    "href": "http://stock.jrj.com.cn/2020/07/21000030301347.shtml",
    "datetime": "2020-07-21 00:00:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]“东诚投资米度签约仪式暨分子影像创新转化研讨会”隆重举行",
    "href": "http://stock.jrj.com.cn/2020/05/26000029999773.shtml",
    "datetime": "2020-05-26 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业子公司签署投资意向书 促进公司在研新药转化效率",
    "href": "http://stock.jrj.com.cn/invest/2020/05/25084529757606.shtml",
    "datetime": "2020-05-25 08:45:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]心系投资者 携手共行动—5.15全国投资者保护宣传日活动",
    "href": "http://stock.jrj.com.cn/2020/05/18000029999771.shtml",
    "datetime": "2020-05-18 00:00:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]集团成功召开2020年一季度经营管理会",
    "href": "http://stock.jrj.com.cn/2020/04/23000029999770.shtml",
    "datetime": "2020-04-23 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：签署共同开发新靶点创新药物合同",
    "href": "http://stock.jrj.com.cn/2020/04/20200729331283.shtml",
    "datetime": "2020-04-20 20:07:00",
    "code": "002675"
  },
  {
    "title": "东诚药业签署共同开发新靶点创新药物合同",
    "href": "http://stock.jrj.com.cn/2020/04/20200529331276.shtml",
    "datetime": "2020-04-20 20:05:25",
    "code": "002675"
  },
  {
    "title": "东诚药业董事兼副总经理齐东绮辞职 2019年薪酬为50万元",
    "href": "http://stock.jrj.com.cn/2020/04/18124529318636.shtml",
    "datetime": "2020-04-18 12:45:35",
    "code": "002675"
  },
  {
    "title": "东诚药业第一季度净利7386.94万同比增长14.49% 销售增加",
    "href": "http://stock.jrj.com.cn/2020/04/18115529318413.shtml",
    "datetime": "2020-04-18 11:55:31",
    "code": "002675"
  },
  {
    "title": "东诚药业：全资子公司获国产保健食品注册证书",
    "href": "http://stock.jrj.com.cn/2020/02/24162928882840.shtml",
    "datetime": "2020-02-24 16:29:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：子公司获得国产保健食品注册证书",
    "href": "http://stock.jrj.com.cn/2020/02/24161128882753.shtml",
    "datetime": "2020-02-24 16:11:34",
    "code": "002675"
  },
  {
    "title": "东诚药业2019年净利1.54亿 同比下滑44.94%",
    "href": "http://stock.jrj.com.cn/2020/02/21195328873166.shtml",
    "datetime": "2020-02-21 19:53:23",
    "code": "002675"
  },
  {
    "title": "东诚药业：商誉减值和公允价值波动导致2019年净利下滑44.94%",
    "href": "http://stock.jrj.com.cn/2020/02/21171528872137.shtml",
    "datetime": "2020-02-21 17:15:00",
    "code": "002675"
  },
  {
    "title": "东诚药业2020年度向银行申请银行授信额度 合计金额54亿7000万元",
    "href": "http://stock.jrj.com.cn/2020/02/18220928850732.shtml",
    "datetime": "2020-02-18 22:09:06",
    "code": "002675"
  },
  {
    "title": "东诚药业：回购期届满 未回购公司股份",
    "href": "http://stock.jrj.com.cn/2020/02/12162028816118.shtml",
    "datetime": "2020-02-12 16:20:22",
    "code": "002675"
  },
  {
    "title": "[东诚药业]市政府李朝晖副市长赴东诚药业现场调研疫情防控和复工复产工作",
    "href": "http://stock.jrj.com.cn/2020/02/12000029999769.shtml",
    "datetime": "2020-02-12 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业已累计向疫区捐赠医用物资917万余元",
    "href": "http://stock.jrj.com.cn/2020/02/10161128803406.shtml",
    "datetime": "2020-02-10 16:11:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]同舟共济 驰援武汉 ——东诚药业45万余元员工捐款驰援武汉",
    "href": "http://stock.jrj.com.cn/2020/02/10000029999768.shtml",
    "datetime": "2020-02-10 00:00:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]驰援武汉,上市公司东诚药业在行动! ——东诚药业总经理忻红波接受山东经济广播专访实录",
    "href": "http://stock.jrj.com.cn/2020/02/06000029999766.shtml",
    "datetime": "2020-02-06 00:00:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]抗击疫情,驰援武汉——东诚药业在行动",
    "href": "http://stock.jrj.com.cn/2020/02/01000029999765.shtml",
    "datetime": "2020-02-01 00:00:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]东诚药业再捐抗疫药物800万 抗击疫情支援疫区",
    "href": "http://stock.jrj.com.cn/2020/02/01000029999764.shtml",
    "datetime": "2020-02-01 00:00:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]致湖北地区合作伙伴一封信",
    "href": "http://stock.jrj.com.cn/2020/02/01000029999763.shtml",
    "datetime": "2020-02-01 00:00:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]致东诚全体员工的一封信",
    "href": "http://stock.jrj.com.cn/2020/02/01000029999767.shtml",
    "datetime": "2020-02-01 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业再捐抗疫药物800万 抗击疫情支援疫区",
    "href": "http://stock.jrj.com.cn/2020/01/31194728745702.shtml",
    "datetime": "2020-01-31 19:47:00",
    "code": "002675"
  },
  {
    "title": "东诚药业累计捐赠医用物资909余万元",
    "href": "http://stock.jrj.com.cn/2020/01/31165928745355.shtml",
    "datetime": "2020-01-31 16:59:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：由集团向武汉各医院捐助首批医用物资100万元",
    "href": "http://stock.jrj.com.cn/2020/01/27182328738012.shtml",
    "datetime": "2020-01-27 18:23:00",
    "code": "002675"
  },
  {
    "title": "东诚药业副总经理胡江滨辞职 2018年薪酬为28万元",
    "href": "http://stock.jrj.com.cn/2020/01/17234028695497.shtml",
    "datetime": "2020-01-17 23:40:10",
    "code": "002675"
  },
  {
    "title": "[东诚药业]“逐梦新时代、砥砺新征程-同心、同向、同行”-东诚药业2020年会隆重举行",
    "href": "http://stock.jrj.com.cn/2020/01/14000029999788.shtml",
    "datetime": "2020-01-14 00:00:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]东诚药业与北京肿瘤医院成功举行99mTc标记美罗华项目合作签约暨核药临床转化基地揭牌仪式",
    "href": "http://stock.jrj.com.cn/2020/01/14000029999762.shtml",
    "datetime": "2020-01-14 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：引进北京肿瘤医院核药产品",
    "href": "http://stock.jrj.com.cn/2020/01/12175828663554.shtml",
    "datetime": "2020-01-12 17:58:00",
    "code": "002675"
  },
  {
    "title": "东诚药业控股子公司通过药品GMP认证检查",
    "href": "http://stock.jrj.com.cn/2020/01/02182728618394.shtml",
    "datetime": "2020-01-02 18:27:42",
    "code": "002675"
  },
  {
    "title": "东诚药业：签订放射性药物战略合作协议 丰富核药产品研发管线",
    "href": "http://stock.jrj.com.cn/2019/10/30174028326574.shtml",
    "datetime": "2019-10-30 17:40:20",
    "code": "002675"
  },
  {
    "title": "东诚药业：与北京肿瘤医院签署战略合作协议",
    "href": "http://stock.jrj.com.cn/2019/10/30162128326170.shtml",
    "datetime": "2019-10-30 16:21:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：与北京肿瘤医院在放射性药物领域战略合作",
    "href": "http://stock.jrj.com.cn/2019/10/30162028326136.shtml",
    "datetime": "2019-10-30 16:20:33",
    "code": "002675"
  },
  {
    "title": "8亿元可转债募资终止 东诚药业回购会否随之“泡汤”？",
    "href": "http://stock.jrj.com.cn/2019/10/30081228323013.shtml",
    "datetime": "2019-10-30 08:12:43",
    "code": "002675"
  },
  {
    "title": "东诚药业第三季度盈利1.01亿 同比增长23.21%",
    "href": "http://stock.jrj.com.cn/2019/10/29164428318675.shtml",
    "datetime": "2019-10-29 16:44:10",
    "code": "002675"
  },
  {
    "title": "[东诚药业]2019年9月21日,东诚药业第八届秋季运动会圆满闭幕",
    "href": "http://stock.jrj.com.cn/2019/09/24000029999790.shtml",
    "datetime": "2019-09-24 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：全资子公司获第二类医疗器械经营备案凭证",
    "href": "http://stock.jrj.com.cn/2019/09/05202428096033.shtml",
    "datetime": "2019-09-05 20:24:25",
    "code": "002675"
  },
  {
    "title": "东诚药业：子公司获第二类医疗器械经营备案凭证",
    "href": "http://stock.jrj.com.cn/2019/09/05195128095950.shtml",
    "datetime": "2019-09-05 19:51:00",
    "code": "002675"
  },
  {
    "title": "东诚药业股东拟减持股份 预计减持不超总股本1.75%",
    "href": "http://stock.jrj.com.cn/2019/08/28101728047535.shtml",
    "datetime": "2019-08-28 10:17:30",
    "code": "002675"
  },
  {
    "title": "东诚药业：持股2.18%的股东拟减持不超1.75%",
    "href": "http://stock.jrj.com.cn/2019/08/27202628042769.shtml",
    "datetime": "2019-08-27 20:26:53",
    "code": "002675"
  },
  {
    "title": "东诚药业：鲁鼎思诚拟减持不超1.75%股份",
    "href": "http://stock.jrj.com.cn/2019/08/27192728042504.shtml",
    "datetime": "2019-08-27 19:27:00",
    "code": "002675"
  },
  {
    "title": "东诚药业股东鲁鼎思诚拟减持不超1.75%股份",
    "href": "http://stock.jrj.com.cn/2019/08/27184028042302.shtml",
    "datetime": "2019-08-27 18:40:06",
    "code": "002675"
  },
  {
    "title": "东诚药业：全资子公司将在中国大陆独家经销尿素[13C]呼气试验产品",
    "href": "http://stock.jrj.com.cn/2019/08/14184227976865.shtml",
    "datetime": "2019-08-14 18:42:02",
    "code": "002675"
  },
  {
    "title": "东诚药业：获得Exalenz旗下检测产品独家经销权 补强诊断类药物产品管线",
    "href": "http://stock.jrj.com.cn/2019/08/14184027976829.shtml",
    "datetime": "2019-08-14 18:40:18",
    "code": "002675"
  },
  {
    "title": "东诚药业：子公司将在中国大陆独家经销尿素[13C]呼气试验产品",
    "href": "http://stock.jrj.com.cn/2019/08/14181727976752.shtml",
    "datetime": "2019-08-14 18:17:00",
    "code": "002675"
  },
  {
    "title": "东诚药业2019年上半年盈利13.3亿 业务持续增长",
    "href": "http://stock.jrj.com.cn/2019/07/31100827907603.shtml",
    "datetime": "2019-07-31 10:08:40",
    "code": "002675"
  },
  {
    "title": "东诚药业：2019年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/07/30205027905317.shtml",
    "datetime": "2019-07-30 20:50:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]东诚药业集团成功召开2019年第二季度经营管理会议",
    "href": "http://stock.jrj.com.cn/2019/07/23000029999786.shtml",
    "datetime": "2019-07-23 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：全资子公司获得药物临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/07/16191127848648.shtml",
    "datetime": "2019-07-16 19:11:18",
    "code": "002675"
  },
  {
    "title": "东诚药业：子公司获得药物临床试验通知书",
    "href": "http://stock.jrj.com.cn/2019/07/16185527848600.shtml",
    "datetime": "2019-07-16 18:55:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]东诚药业荣登中国医药工业百强榜",
    "href": "http://stock.jrj.com.cn/2019/07/16000029999784.shtml",
    "datetime": "2019-07-16 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业副总经理仰振球辞职 2018年薪酬为39万元",
    "href": "http://stock.jrj.com.cn/2019/06/30174927774218.shtml",
    "datetime": "2019-06-30 17:49:34",
    "code": "002675"
  },
  {
    "title": "[东诚药业]公司参加第十九届世界制药原料中国展(CPhI China 2019)",
    "href": "http://stock.jrj.com.cn/2019/06/26000029999779.shtml",
    "datetime": "2019-06-26 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业被要求重新描述主营：需简明易懂 而非摘抄工商登记经营范围",
    "href": "http://stock.jrj.com.cn/2019/06/18143227719782.shtml",
    "datetime": "2019-06-18 14:32:24",
    "code": "002675"
  },
  {
    "title": "[东诚药业]“东诚药业上市七周年庆暨东诚核医药产业发展论坛”隆重举行",
    "href": "http://stock.jrj.com.cn/2019/05/30000029999777.shtml",
    "datetime": "2019-05-30 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/05/22224027609183.shtml",
    "datetime": "2019-05-22 22:40:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：上半年净利同比预增50%-65%",
    "href": "http://stock.jrj.com.cn/2019/05/22213727608922.shtml",
    "datetime": "2019-05-22 21:37:54",
    "code": "002675"
  },
  {
    "title": "东诚药业：半年度业绩同比预增50%-65%",
    "href": "http://stock.jrj.com.cn/2019/05/22200827608633.shtml",
    "datetime": "2019-05-22 20:08:39",
    "code": "002675"
  },
  {
    "title": "东诚药业：下属公司获药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/05/07165927537930.shtml",
    "datetime": "2019-05-07 16:59:12",
    "code": "002675"
  },
  {
    "title": "东诚药业下属公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/05/07165727537925.shtml",
    "datetime": "2019-05-07 16:57:27",
    "code": "002675"
  },
  {
    "title": "东诚药业：下属公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/05/07165027537910.shtml",
    "datetime": "2019-05-07 16:50:00",
    "code": "002675"
  },
  {
    "title": "[东诚药业]东诚药业集团成功召开2019年第一季度\"同心、同向、同行\"经营管理会议",
    "href": "http://stock.jrj.com.cn/2019/04/24000029999778.shtml",
    "datetime": "2019-04-24 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业引入战略股东嘉兴聚力",
    "href": "http://stock.jrj.com.cn/2019/03/05011727116833.shtml",
    "datetime": "2019-03-05 01:17:05",
    "code": "002675"
  },
  {
    "title": "东诚药业控股股东、实控人拟3.86亿转让5%公司股份 引进战略投资",
    "href": "http://stock.jrj.com.cn/2019/03/04135027114580.shtml",
    "datetime": "2019-03-04 13:50:01",
    "code": "002675"
  },
  {
    "title": "东诚药业控股股东、实控人拟转让5%股份 引入战投嘉兴聚力",
    "href": "http://stock.jrj.com.cn/2019/03/03175527110756.shtml",
    "datetime": "2019-03-03 17:55:11",
    "code": "002675"
  },
  {
    "title": "东诚药业：控股股东、实控人拟转让5%股份 引入战略股东嘉兴聚力",
    "href": "http://stock.jrj.com.cn/2019/03/03173927110746.shtml",
    "datetime": "2019-03-03 17:39:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：控股股东、实控人拟转让5%股份引入战投嘉兴聚力",
    "href": "http://stock.jrj.com.cn/2019/03/03173527110731.shtml",
    "datetime": "2019-03-03 17:35:11",
    "code": "002675"
  },
  {
    "title": "东诚药业：实控人拟转让5%股份引入战略投资者",
    "href": "http://stock.jrj.com.cn/2019/03/03173427110730.shtml",
    "datetime": "2019-03-03 17:34:14",
    "code": "002675"
  },
  {
    "title": "年报首批社保基金持仓曝光 连续4个季度坚守海翔药业东诚药业",
    "href": "http://stock.jrj.com.cn/2019/02/21092527069767.shtml",
    "datetime": "2019-02-21 09:25:00",
    "code": "002675"
  },
  {
    "title": "年报首批社保基金持仓曝光 连续4个季度坚守2股",
    "href": "http://stock.jrj.com.cn/2019/02/21010727068479.shtml",
    "datetime": "2019-02-21 01:07:51",
    "code": "002675"
  },
  {
    "title": "东诚药业豪掷30亿布局核医药领域 前途难料",
    "href": "http://stock.jrj.com.cn/2019/02/14072027042171.shtml",
    "datetime": "2019-02-14 07:20:53",
    "code": "002675"
  },
  {
    "title": "东诚药业拟发可转债 募资8亿元半数用于回购",
    "href": "http://stock.jrj.com.cn/2019/02/14010827040269.shtml",
    "datetime": "2019-02-14 01:08:55",
    "code": "002675"
  },
  {
    "title": "早间公告：华映科技控股股东可能变更；东诚药业拟发行不超8亿元可转债",
    "href": "http://stock.jrj.com.cn/2019/02/13082227037025.shtml",
    "datetime": "2019-02-13 08:22:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：账面商誉逼近27亿未爆雷 是否可以高枕无忧",
    "href": "http://stock.jrj.com.cn/2019/02/13070927036664.shtml",
    "datetime": "2019-02-13 07:09:05",
    "code": "002675"
  },
  {
    "title": "东诚药业：年报净利同比增62% 拟10派0.48元",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/01075927011495.shtml",
    "datetime": "2019-02-01 07:59:56",
    "code": "002675"
  },
  {
    "title": "东诚药业：2018年年度报告主要财务指标及分配预案",
    "href": "http://stock.jrj.com.cn/2019/01/31203027009448.shtml",
    "datetime": "2019-01-31 20:30:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：2018年净利同比增46% 拟10派0.48元",
    "href": "http://stock.jrj.com.cn/2019/01/31200227009366.shtml",
    "datetime": "2019-01-31 20:02:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：2018年净利2.8亿元 拟10派0.48元",
    "href": "http://stock.jrj.com.cn/2019/01/31195727009333.shtml",
    "datetime": "2019-01-31 19:57:24",
    "code": "002675"
  },
  {
    "title": "东诚药业2018年度净利润同比增长62.44%",
    "href": "http://stock.jrj.com.cn/2019/01/31195727009361.shtml",
    "datetime": "2019-01-31 19:57:12",
    "code": "002675"
  },
  {
    "title": "东诚药业：拟斥资1亿至2亿元回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/11075926888549.shtml",
    "datetime": "2019-01-11 07:59:59",
    "code": "002675"
  },
  {
    "title": "东诚药业：拟1亿元至2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2019/01/10213226887010.shtml",
    "datetime": "2019-01-10 21:32:31",
    "code": "002675"
  },
  {
    "title": "东诚药业：拟收购广东回旋等5家公司",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/08075926870944.shtml",
    "datetime": "2019-01-08 07:59:59",
    "code": "002675"
  },
  {
    "title": "东诚药业牵手韩国DCB加固核医药领先地位",
    "href": "http://stock.jrj.com.cn/2018/12/25001326796171.shtml",
    "datetime": "2018-12-25 00:13:20",
    "code": "002675"
  },
  {
    "title": "东诚药业：下属公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/14080025342676.shtml",
    "datetime": "2018-11-14 08:00:01",
    "code": "002675"
  },
  {
    "title": "东诚药业：下属公司获药品GMP证书",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/14080025342674.shtml",
    "datetime": "2018-11-14 08:00:01",
    "code": "002675"
  },
  {
    "title": "东诚药业：下属公司获药品GMP证书 新增一个核药中心",
    "href": "http://stock.jrj.com.cn/2018/11/13172725340031.shtml",
    "datetime": "2018-11-13 17:27:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/27000025266784.shtml",
    "datetime": "2018-10-27 00:00:01",
    "code": "002675"
  },
  {
    "title": "东诚药业股东东益生物、由守谊合计补充质押1500万股",
    "href": "http://stock.jrj.com.cn/2018/10/25075525257035.shtml",
    "datetime": "2018-10-25 07:55:00",
    "code": "002675"
  },
  {
    "title": "东诚药业股东质押796万股 占比7.38%",
    "href": "http://stock.jrj.com.cn/2018/10/19111225227701.shtml",
    "datetime": "2018-10-19 11:12:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：全资子公司体内放射性药品获GMP证书",
    "href": "http://stock.jrj.com.cn/hotstock/2018/10/11075925184562.shtml",
    "datetime": "2018-10-11 07:59:51",
    "code": "002675"
  },
  {
    "title": "东诚药业下属公司获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2018/10/10201025183046.shtml",
    "datetime": "2018-10-10 20:10:02",
    "code": "002675"
  },
  {
    "title": "东诚药业：子公司体内放射性药品获GMP证书",
    "href": "http://stock.jrj.com.cn/2018/10/10195025182937.shtml",
    "datetime": "2018-10-10 19:50:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：拟与中科院近代物理所设立新型核素及核药创新研发公司",
    "href": "http://stock.jrj.com.cn/2018/09/09174525066574.shtml",
    "datetime": "2018-09-09 17:45:00",
    "code": "002675"
  },
  {
    "title": "东诚药业与国投聚力达成框架协议 核医药竞争能力将获提升",
    "href": "http://stock.jrj.com.cn/2018/09/06110225056561.shtml",
    "datetime": "2018-09-06 11:02:29",
    "code": "002675"
  },
  {
    "title": "东诚药业与国投聚力达成框架协议 核医药竞争能力将获提升",
    "href": "http://stock.jrj.com.cn/2018/09/06110225096368.shtml",
    "datetime": "2018-09-06 11:02:29",
    "code": "002675"
  },
  {
    "title": "东诚药业：拟与国投聚力就核医药相关领域展开合作",
    "href": "http://stock.jrj.com.cn/hotstock/2018/09/06080025055218.shtml",
    "datetime": "2018-09-06 08:00:02",
    "code": "002675"
  },
  {
    "title": "东诚药业：拟与国投聚力合作 加强核医药相关领域投资",
    "href": "http://stock.jrj.com.cn/2018/09/05201025052000.shtml",
    "datetime": "2018-09-05 20:10:00",
    "code": "002675"
  },
  {
    "title": "早间公告：如意集团拟投资维信基金；东诚药业拟建核医药创新研发产业园",
    "href": "http://stock.jrj.com.cn/2018/08/15082524953092.shtml",
    "datetime": "2018-08-15 08:25:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：成立创新研究院",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/13075924942943.shtml",
    "datetime": "2018-08-13 07:59:59",
    "code": "002675"
  },
  {
    "title": "东诚药业：上半年净利1.12亿元 同比增54%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/13075924942942.shtml",
    "datetime": "2018-08-13 07:59:59",
    "code": "002675"
  },
  {
    "title": "东诚药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/10194024938924.shtml",
    "datetime": "2018-08-10 19:40:00",
    "code": "002675"
  },
  {
    "title": "东诚药业王永辉：企业在发展转型过程中要量力而行",
    "href": "http://stock.jrj.com.cn/2018/07/03111224762056.shtml",
    "datetime": "2018-07-03 11:12:27",
    "code": "002675"
  },
  {
    "title": "东诚药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/24220024443031.shtml",
    "datetime": "2018-04-24 22:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业股东违规套现3551万元",
    "href": "http://stock.jrj.com.cn/2018/04/17100524400657.shtml",
    "datetime": "2018-04-17 10:05:50",
    "code": "002675"
  },
  {
    "title": "老总访谈 | 产业链整合抢得先机，东诚药业要做核药界“阿里”",
    "href": "http://stock.jrj.com.cn/2018/04/12101728697746.shtml",
    "datetime": "2018-04-12 10:17:01",
    "code": "002675"
  },
  {
    "title": "东诚药业董事长由守谊表示 今年核医药板块营收占比将超50%",
    "href": "http://stock.jrj.com.cn/2018/04/11075124372374.shtml",
    "datetime": "2018-04-11 07:51:00",
    "code": "002675"
  },
  {
    "title": "东诚药业将受益PET-CT审批权下放新政",
    "href": "http://stock.jrj.com.cn/2018/04/10175124369339.shtml",
    "datetime": "2018-04-10 17:51:42",
    "code": "002675"
  },
  {
    "title": "[东诚药业]顺势有道,回归本路",
    "href": "http://stock.jrj.com.cn/2018/04/04000024352684.shtml",
    "datetime": "2018-04-04 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：定增获证监会无条件通过",
    "href": "http://stock.jrj.com.cn/2018/03/08145224211686.shtml",
    "datetime": "2018-03-08 14:52:00",
    "code": "002675"
  },
  {
    "title": "医药股受追捧集体爆发 东诚药业等6股涨停",
    "href": "http://stock.jrj.com.cn/2018/03/08132224211129.shtml",
    "datetime": "2018-03-08 13:22:42",
    "code": "002675"
  },
  {
    "title": "东诚药业：公司股票复牌的公告",
    "href": "http://stock.jrj.com.cn/2018/03/07205024207566.shtml",
    "datetime": "2018-03-07 20:50:00",
    "code": "002675"
  },
  {
    "title": "东诚药业回应拟用配套融资置换对价贷款",
    "href": "http://stock.jrj.com.cn/2018/02/12221824109446.shtml",
    "datetime": "2018-02-12 22:18:11",
    "code": "002675"
  },
  {
    "title": "[东诚药业]2018年1月27日东诚药业年会隆重举行",
    "href": "http://stock.jrj.com.cn/2018/01/30000024030557.shtml",
    "datetime": "2018-01-30 00:00:00",
    "code": "002675"
  },
  {
    "title": "27日停复牌：东诚药业拟16亿收购安迪科 27日复牌",
    "href": "http://stock.jrj.com.cn/2017/11/27082423698510.shtml",
    "datetime": "2017-11-27 08:24:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：拟16亿收购安迪科 27日复牌",
    "href": "http://stock.jrj.com.cn/2017/11/26174023696837.shtml",
    "datetime": "2017-11-26 17:40:39",
    "code": "002675"
  },
  {
    "title": "东诚药业：调整方案尽快推进重组 明日开市起停牌",
    "href": "http://stock.jrj.com.cn/2017/10/22192023267262.shtml",
    "datetime": "2017-10-22 19:20:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：实控人拟不超5000万元增持 公司股票复牌后急跌近两成",
    "href": "http://stock.jrj.com.cn/2017/07/18204022766580.shtml",
    "datetime": "2017-07-18 20:40:00",
    "code": "002675"
  },
  {
    "title": "东诚药业：关于公司股票复牌的提示性公告",
    "href": "http://stock.jrj.com.cn/2017/07/16173022754765.shtml",
    "datetime": "2017-07-16 17:30:00",
    "code": "002675"
  },
  {
    "title": "[哈药股份]东诚药业拟16亿元收购安迪科加码核医药业务",
    "href": "http://stock.jrj.com.cn/2017/07/03000031006695.shtml",
    "datetime": "2017-07-03 00:00:00",
    "code": "002675"
  },
  {
    "title": "东诚药业拟支付现金并发行股份购买安迪科100%股权",
    "href": "http://stock.jrj.com.cn/2017/06/30075922677275.shtml",
    "datetime": "2017-06-30 07:59:56",
    "code": "002675"
  },
  {
    "title": "东诚药业步入快速成长期",
    "href": "http://stock.jrj.com.cn/2017/05/26041922536226.shtml",
    "datetime": "2017-05-26 04:19:02",
    "code": "002675"
  },
  {
    "title": "东诚药业收到财政补贴300万",
    "href": "http://stock.jrj.com.cn/2016/12/29170121906895.shtml",
    "datetime": "2016-12-29 17:01:33",
    "code": "002675"
  },
  {
    "title": "东诚药业：股东减持计划完成 对股价影响有限",
    "href": "http://stock.jrj.com.cn/2016/12/09203321818258.shtml",
    "datetime": "2016-12-09 20:33:26",
    "code": "002675"
  },
  {
    "title": "[互动]东诚药业：截至9月14日股东数为29646人",
    "href": "http://stock.jrj.com.cn/2016/09/20144421506382.shtml",
    "datetime": "2016-09-20 14:44:57",
    "code": "002675"
  },
  {
    "title": "306公司抢发三季报预告 东诚药业等24股连涨5日以上",
    "href": "http://stock.jrj.com.cn/hotstock/2016/08/19002421338711.shtml",
    "datetime": "2016-08-19 00:24:06",
    "code": "002675"
  },
  {
    "title": "快讯：东诚药业控股股东提议中期10转20 股价涨停",
    "href": "http://stock.jrj.com.cn/2016/07/06093121155622.shtml",
    "datetime": "2016-07-06 09:31:11",
    "code": "002675"
  },
  {
    "title": "东诚药业以6975万美元收购医疗行业公司",
    "href": "http://stock.jrj.com.cn/2016/03/25204220742372.shtml",
    "datetime": "2016-03-25 20:42:19",
    "code": "002675"
  },
  {
    "title": "东诚药业：拟出资2100万元增资入股上海宇研生物技",
    "href": "http://stock.jrj.com.cn/hotstock/2016/03/18075920707512.shtml",
    "datetime": "2016-03-18 07:59:56",
    "code": "002675"
  },
  {
    "title": "东诚药业今日停牌 拟筹划资产收购事项",
    "href": "http://stock.jrj.com.cn/2016/02/15121920555492.shtml",
    "datetime": "2016-02-15 12:19:04",
    "code": "002675"
  },
  {
    "title": "东诚药业：收到专项财政补贴1000万元",
    "href": "http://stock.jrj.com.cn/hotstock/2015/01/23075918754549.shtml",
    "datetime": "2015-01-23 07:59:47",
    "code": "002675"
  },
  {
    "title": "东诚药业收到财政补贴110万元",
    "href": "http://stock.jrj.com.cn/2014/09/03165217942336.shtml",
    "datetime": "2014-09-03 16:52:41",
    "code": "002675"
  },
  {
    "title": "东诚生化：取得发明专利证书",
    "href": "http://stock.jrj.com.cn/hotstock/2014/05/07075917163900.shtml",
    "datetime": "2014-05-07 07:59:53",
    "code": "002675"
  },
  {
    "title": "东诚生化：子公司你拟认定为高新技术企业",
    "href": "http://stock.jrj.com.cn/hotstock/2013/12/16080016334147.shtml",
    "datetime": "2013-12-16 08:00:33",
    "code": "002675"
  },
  {
    "title": "东诚生化使用1.3亿闲置募资购买理财产品",
    "href": "http://stock.jrj.com.cn/2013/07/02121615473250.shtml",
    "datetime": "2013-07-02 12:16:38",
    "code": "002675"
  },
  {
    "title": "东诚生化：1.67亿购大洋制药八成股权",
    "href": "http://stock.jrj.com.cn/2013/05/23004215327901.shtml",
    "datetime": "2013-05-23 00:42:00",
    "code": "002675"
  },
  {
    "title": "东诚生化上市首年“变脸” 背离行业表现惹包装疑云",
    "href": "http://stock.jrj.com.cn/2013/03/05061115109471.shtml",
    "datetime": "2013-03-05 06:11:00",
    "code": "002675"
  },
  {
    "title": "首批无锁定期次新股遭“滑铁卢” 全流通终结新股暴利",
    "href": "http://stock.jrj.com.cn/ipo/2012/05/29070413295501.shtml",
    "datetime": "2012-05-29 07:04:00",
    "code": "002675"
  },
  {
    "title": "东诚生化龙虎榜数据一览(5/28)",
    "href": "http://stock.jrj.com.cn/hotstock/2012/05/28174213288839.shtml",
    "datetime": "2012-05-28 17:42:37",
    "code": "002675"
  },
  {
    "title": "东诚生化：合理均值区间价为24.21元-25.59元",
    "href": "http://stock.jrj.com.cn/ipo/2012/05/25004513256998.shtml",
    "datetime": "2012-05-25 00:45:01",
    "code": "002675"
  },
  {
    "title": "东诚生化等三中小板公司将于25日上市交易",
    "href": "http://stock.jrj.com.cn/ipo/2012/05/23183213240475.shtml",
    "datetime": "2012-05-23 18:32:00",
    "code": "002675"
  },
  {
    "title": "东诚生化凭什么超募209%？",
    "href": "http://stock.jrj.com.cn/2012/05/21063113199289.shtml",
    "datetime": "2012-05-21 06:31:46",
    "code": "002675"
  },
  {
    "title": "东诚生化等四新股15日申购指南",
    "href": "http://stock.jrj.com.cn/ipo/2012/05/15063913119246.shtml",
    "datetime": "2012-05-15 06:39:50",
    "code": "002675"
  },
  {
    "title": "东诚生化等四新股5月15日申购指南",
    "href": "http://stock.jrj.com.cn/ipo/2012/05/14143113109727.shtml",
    "datetime": "2012-05-14 14:31:00",
    "code": "002675"
  },
  {
    "title": "新股超募现象依然存在 东诚生化超募逾两倍",
    "href": "http://stock.jrj.com.cn/ipo/2012/05/14074213102867.shtml",
    "datetime": "2012-05-14 07:42:00",
    "code": "002675"
  },
  {
    "title": "按新股发行新政策发行 东诚生化超募高达两倍",
    "href": "http://stock.jrj.com.cn/ipo/2012/05/14005113098072.shtml",
    "datetime": "2012-05-14 00:51:27",
    "code": "002675"
  },
  {
    "title": "东诚生化：机构询价热情高",
    "href": "http://stock.jrj.com.cn/ipo/2012/05/09110913049318.shtml",
    "datetime": "2012-05-09 11:09:27",
    "code": "002675"
  },
  {
    "title": "东诚生化今日招股 产品多元销售网络强大",
    "href": "http://stock.jrj.com.cn/ipo/2012/05/04105612996377.shtml",
    "datetime": "2012-05-04 10:56:03",
    "code": "002675"
  }
]